Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2.
Resch MD, Wen K, Mazboudi R, Mulhall Maasz H, Persaud M, Garvey K, Gallardo L, Gottlieb P, Alimova A, Khayat R, Morales J, Bielefeldt-Ohmann H, Bowen RA, Galarza JM.
Resch MD, et al. Among authors: galarza jm.
Vaccines (Basel). 2022 Nov 24;10(12):1997. doi: 10.3390/vaccines10121997.
Vaccines (Basel). 2022.
PMID: 36560407
Free PMC article.